GLI1 and acute myeloid leukemia: To compare the relative preponderance of canonical vs. non-canonical HH signaling in AML, we analyzed the impact of GANT61 as direct GLI inhibitor to the SMO inhibitor cyclopamine with regard to their ability to block the GLI promoter activity in a reporter assay.